期刊文献+

PI3K抑制剂ZSTK-474对结直肠癌细胞增殖和侵袭的影响 被引量:5

Effect of PI3K inhibitor ZSTK-474 on proliferation and invasion of colorectal cancer cells
下载PDF
导出
摘要 目的:探讨PI3K抑制剂ZSTK-474对结直肠癌细胞增殖和侵袭的影响。方法:采用不同浓度(0、1、2、4、6、8和10μmol/L)ZSTK-474处理结直肠癌HT-29和HCT-116细胞24 h和48 h,CCK8法检测细胞增殖活性并计算出ZSTK-474在两株结直肠癌细胞中的半数抑制浓度(IC50)。根据IC50的值选用浓度为4μmol/L的ZSTK-474作用HT-29和HCT-116细胞24 h,同时设置加入等量的0.1%DMSO为对照。采用平板克隆形成实验检测细胞增殖,流式细胞仪检测细胞凋亡,qRT-PCR检测细胞PI3K、Akt的mRNA水平,Western blot检测细胞PI3K、Akt的蛋白水平。结果:ZSTK-474可明显抑制HT-29和HCT-116细胞的增殖,且呈时间和剂量依赖性。ZSTK-474可抑制HT-29和HCT-116细胞的侵袭能力,但不影响其凋亡。ZSTK-474处理HT-29和HCT-116细胞24 h后,PI3K和Akt的mRNA和蛋白表达水平均显著下降。结论:ZSTK-474能够抑制结直肠癌细胞增殖,并且能抑制其侵袭。 Toinvestigate the effect of ZSTK-474 on proliferation and invasion of colorectal cancer cells.Methods:HT-29 and HCT-116 cells were treated with different concentrations(0,1,2,4,6,8 and 10μmol/L)of ZSTK-474 for 24 h and 48 h.CCK8 assay was used to determine the cell viability,and the half ihhibitory concentration(IC)was calculated.HT-29 and HCT-116 cells treated with 4μmol/L ZSTK-474 were used as the experimental group according to the value of IC,and those treated with 0.1%DMSO as the control group.The cell proliferation was detected by Colony-forming assay.Cell apoptosis was examined by flow cytometry,and cell invasion was evaluated by Transwell assay.The mRNA expression of PI3K and Akt were determined by qRT-PCR,and the protein expression of PI3K and Akt were assessed by Western blot.Results:ZSTK-474 significantly inhibited the proliferation and invasion of HT-29 and HCT-116 cells in a time and dose dependent manner.ZSTK-474 did not affect the apoptosis of HT-29 and HCT-116 cells.The mRNA and protein expression of PI3K and Akt were inhibited in HT-29 and HCT-116 cells with ZSTK-474 treated for 24 h.Conclusion:ZSTK-474 inhibits colorectal cancer cells proliferation and invasion in vitro.
作者 李东 朱长利 万玉峰 Li Dong;Zhu Changli;Wan Yufeng(The Affiliated Huai'an Hospital of Xuzhou Medical University,the Second People's Hospital of Huai'an,Jiangsu Huai'an 223002,China.)
出处 《现代肿瘤医学》 CAS 2020年第4期548-552,共5页 Journal of Modern Oncology
关键词 结直肠癌 细胞增殖 细胞侵袭 ZSTK-474 colorectal cancer cell proliferation cell invasion ZSTK-474
  • 相关文献

参考文献4

二级参考文献98

  • 1Yamori T, Matsunaga A, Sato S, Yamazaki K, Komi A, Ishizu K, et al. Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Cancer Res 1999; 59: 4042-9.
  • 2Nakatsu N, Nakamura T, Yamazaki K, Sadahiro S, Makuuchi H, Kanno J, et al. Evaluation of action mechanisms of toxic chemicals using JFCR39, a panel of human cancer cell lines. Mol Pharmacol 2007;72: 1171-80.
  • 3Dan S, Tsunoda T, Kitahara O, Yanagawa R, Zembutsu H, Katagiri T, et al. An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. Cancer Res 2002; 62: 1139-47.
  • 4YamoriT. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatfcs. Cancer Chemother Pharmacol 2003; 52 Suppl 1: S74-9.
  • 5Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 2006; 6: 813-23.
  • 6Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-12.
  • 7Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991; 83: 757-66.
  • 8Paull KD, Shoemaker RH, Hodes L, Monks A, Scudiero DA, Rubinstein L, et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J Natl Cancer Inst 1989; 81: 1088-92.
  • 9Kong D, Dan S, Yamazaki K, Yamori T. Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against PI3K superfamily and human cancer cell line panel JFCR39. Eur J Cancer 2010; 46: 1111- 21.
  • 10Naasani I, Seimiya H, Yamori T, Tsuruo T. FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Res 1999; 59: 4004-11.

共引文献299

同被引文献37

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部